Fathom Holdings announces proposed common stock offering

Rithm Capital has successfully priced a $190 million preferred stock offering, a move that highlights the company's strong position in the financial market. This offering is significant as it allows Rithm to raise capital for future investments and growth opportunities, which could enhance shareholder value and strengthen its market presence.

Reviva Pharmaceuticals has announced a public offering of common stock, a move that could provide the company with essential capital to further its research and development efforts. This offering is significant as it reflects the company's growth strategy and commitment to advancing its innovative therapies, which could ultimately benefit patients and investors alike.

Jasper Therapeutics has announced a public offering of common stock, which is a significant move for the company as it seeks to raise capital for its ongoing projects. This offering could provide the necessary funds to advance their innovative therapies, potentially benefiting patients and investors alike. It's an exciting time for Jasper as they position themselves for future growth.

BioCardia has successfully priced a $6 million public offering of common stock and warrants, marking a significant step in its financial strategy. This move not only strengthens the company's capital base but also signals confidence in its growth potential. Investors are likely to view this offering as a positive development, as it provides BioCardia with the necessary funds to advance its innovative therapies and expand its market presence.

Diversified Energy has announced a significant secondary offering worth $78.6 million in the US, marking a strategic move to bolster its financial position and expand its operations. This offering is expected to attract investor interest and enhance the company's growth potential, reflecting confidence in its business model and market prospects.

Co-Diagnostics has successfully priced a registered direct offering worth $3.8 million, which is a significant step for the company as it seeks to bolster its financial resources. This funding will likely enhance their capabilities in developing diagnostic solutions, which is crucial in the ever-evolving healthcare landscape. Investors are optimistic about the potential growth this capital infusion could bring, making it a noteworthy development in the biotech sector.

Adtran Holdings has successfully priced a $175 million offering of convertible notes, a move that reflects confidence in its financial strategy and growth potential. This offering is significant as it allows the company to raise capital while providing investors with an opportunity to convert their notes into equity, potentially benefiting from future growth. Such financial maneuvers are crucial for companies looking to expand and innovate in a competitive market.

ADTRAN has successfully priced a $175 million offering of convertible notes at an attractive 3.75%. This move is significant as it allows the company to raise capital while providing investors with a potential equity stake in the future. Such financial strategies can enhance ADTRAN's growth prospects and strengthen its market position, making it a noteworthy development in the finance sector.

Carlyle has successfully priced its $800 million senior notes offering at an attractive 5.050%. This move is significant as it reflects Carlyle's strong position in the market and its ability to secure favorable financing terms. Investors may view this as a positive indicator of the firm's financial health and growth potential, making it a noteworthy development in the finance sector.

Honeywell's unit, Solstice, has successfully priced a $1 billion senior notes offering, marking a significant financial move that reflects the company's strong market position. This offering is expected to enhance Solstice's capital structure and provide the necessary funds for future growth initiatives. Investors are likely to view this positively, as it indicates confidence in the company's strategic direction and financial health.

Fulton Financial has announced its quarterly dividends for both common and preferred stock, reflecting the company's strong financial health and commitment to returning value to its shareholders. This move is significant as it not only rewards investors but also signals confidence in the company's ongoing performance and stability in the market.

Pebblebrook Hotel Trust has announced a $350 million offering of convertible notes, a move that highlights the company's strategy to raise capital for future investments. This offering is significant as it allows the company to attract investors while providing them with the option to convert their notes into equity, potentially enhancing shareholder value. Such financial maneuvers are crucial for the hospitality sector, especially in a recovering economy.

The Bank of Japan has decided to keep interest rates unchanged while it evaluates the potential impact of U.S. tariffs on the Japanese economy. This decision reflects a cautious approach as the central bank navigates uncertain economic conditions, highlighting the interconnectedness of global markets and the importance of monitoring external factors.

Amy Xie Patrick from Pendal Group emphasizes the need to differentiate between bonds and equities, suggesting that their performance is influenced by factors like tariffs. She reassures viewers that the Federal Reserve is not in a state of panic, providing a measured outlook on the markets. This perspective is important as it helps investors understand the current economic landscape and make informed decisions.

Indonesia's largest lender, PT Bank Mandiri, has reduced its loan growth target for the year, even after receiving new government funds aimed at boosting lending and supporting the economy. This decision raises concerns about the overall economic outlook and the effectiveness of government stimulus measures.

Investors are closely monitoring the Bank of Japan's recent decision to maintain its current interest rates, a move that reflects the central bank's cautious approach to economic recovery. This decision is significant as it impacts financial markets and investor confidence, highlighting the ongoing challenges Japan faces in stimulating growth while managing inflation.

The Bank of Japan (BOJ) has decided to maintain its current interest rates while also initiating the sale of exchange-traded funds (ETFs). This move is significant as it reflects the BOJ's ongoing strategy to manage economic stability and influence market conditions. By keeping interest rates steady, the BOJ aims to support growth, while the sale of ETFs indicates a shift in its approach to asset management, potentially impacting investors and the broader economy.

US grain futures saw a significant rise on Friday, fueled by optimism surrounding an anticipated phone call between President Donald Trump and Chinese President Xi Jinping. Traders are hopeful that this conversation could lead to a resolution in the ongoing economic tensions between the two countries, which would be a positive development for the agricultural sector and the broader economy.